An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
מצבים רפואיים
Progressive Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Tejaswini Kulkarni)University of Southern California, Los Angeles, California, United States
Contact: Principal Investigator (Toby Maher)University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Joyce Lee)Contact: Principal Investigator (Joyce Lee, MD)Renstar Medical Research, Ocala, Florida, United States
Contact: Study coordinator (Raj Karunakara)Contact: Principal Investigator (Raj Karunakara, MD)Piedmont Healthcare, Inc., Atlanta, Georgia, United States
Contact: Study coordinator (Amy Case)Contact: Principal Investigator (Amy Case, MD)The University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Study coordinator (Mark Hamblin, MD)Contact: Principal Investigator (Mark Hamblin, MD)University of Maryland, Baltimore, Maryland, United States
Contact: Principal Investigator (Edward Britt)Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Matthew Lammi, MD)Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Andrew Limper)Contact: Study coordinator (Sam Nascak)Contact: Principal Investigator (Andrew Limper, MD)Hannibal Regional Healthcare System, Inc., Hannibal, Missouri, United States
Contact: Study coordinator (Humam Farah, MD)Contact: Principal Investigator (Humam Farah, MD)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Maria Padilla)Contact: Principal Investigator (Maria Padilla, MD)Columbia University, New York, New York, United States
Contact: Study coordinator (Claire McGroder)Contact: Principal Investigator (Claire McGroder, MD)Piedmont HealthCare, PA, Statesville, North Carolina, United States
Contact: Study coordinator (Jose Perez)Contact: Principal Investigator (Jose Perez, MD)Southeastern Research Center, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Jason Thomason, MD)University of Cincinnati, Cincinnati, Ohio, United States
Contact: Study coordinator (Nishant Gupta)Contact: Principal Investigator (Nishant Gupta, MD)Summit Health, Bend, Oregon, United States
Contact: Study coordinator (Jeremy Feldman, MD)Contact: Principal Investigator (Jeremy Feldman, MD)Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Ross Summer)Contact: Principal Investigator (Ross Summer, MD)Temple University Hospital, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Gerard Criner, MD)Contact: Principal Investigator (Gerard Criner, MD)Lowcountry Lung and Critical Care, PA, Charleston, South Carolina, United States
Contact: Study coordinator (Thomas Kaelin, Jr, DO)Contact: Principal Investigator (Thomas Kaelin, Jr., DO)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Study coordinator (Timothy Whelan)Contact: Principal Investigator (Timothy Whelan, MD)Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Study coordinator (Justin Hewlett, MD)Contact: Principal Investigator (Justin Hewlett, MD)El Paso Pulmonary Association, P.A., El Paso, Texas, United States
Contact: Study coordinator (Carlo Hatem, MD)Contact: Principal Investigator (Carlo Hatem, MD)Intermountain Medical Center, Murray, Utah, United States
Contact: Study coordinator (Peter Crossno, MD)Contact: Principal Investigator (Peter Crossno, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Mary Beth Scholand, MD)Inova Healthcare, Falls Church, Virginia, United States
Contact: Principal Investigator (Vikramjit Khangoora)Westmead Hospital, Westmead, New South Wales, Australia
Contact: Principal Investigator (John Wheatley)The Queen Elizabeth Hospital, Woodville South, South Australia, Australia
Royal Prince Alfred Hospital, Camperdown, Australia
Contact: Principal Investigator (Tamera Corte)The Prince Charles Hospital (TPCH), Chermside, Australia
Contact: Principal Investigator (Peter Hopkins)Lung & Sleep Victoria, Footscray, Australia
Contact: Study coordinator (Ian Glaspole)Contact: Principal Investigator (Ian Glaspole)Respiratory Clinical Trials PTY Ltd, Kent Town, Australia
Contact: Principal Investigator (Michael Chia)Nepean Lung & Sleep, Kingston, Australia
Contact: Study coordinator (Donald Lee)Contact: Principal Investigator (Donald Lee)Univ of Western Australia / Institute for Respiratory Health, Nedlands, Australia
Contact: Principal Investigator (Vidya Navaratnam)John Hunter Hospital, New Lambton Heights, Australia
Contact: Study coordinator (Christopher Grainge) · christopher.grainge@health.nsw.gov.au · 000-000-000Contact: Principal Investigator (Christopher Grainge)Dynamic Drug Advancement, Ajax, Ontario, Canada
Contact: Principal Investigator (George Philteos)Research Institute McGill University Health Center, Montreal, Quebec, Canada
Contact: Principal Investigator (Deborah Assayag)CIC Mauricie, Trois-Rivières, Quebec, Canada
Contact: Principal Investigator (Emilie Millaire)Centre for Lung Health, Vancouver, Vancouver, Canada
Contact: Principal Investigator (Daniel Marinescu)Fakultni Thomayerove nemocnice, Praha Klanovice, Czechia
Contact: Principal Investigator (Martina Sterclova)University of Montpellier, Montrevel-en-Bresse, Montpellier, France
Contact: Study coordinator (Arnaud Bourdin)Contact: Principal Investigator (Arnaud Bourdin)Centre Hospitalier Universitaire d'Angers, Angers, France
Contact: Study coordinator (Frederic Gagnadoux, MD)Medizinische Hochschule Hannover, Hanover, Lower Saxony, Germany
Contact: Principal Investigator (Jonas Schupp)Fondazione IRCCS Policlinico San Matteo - UOC Pneumologia, Pavia, Lombardy, Italy
Contact: Study coordinator (Angelo Guido Corsico, MD)St Antonius Hospital, Nieuwegein, Netherlands
Contact: Principal Investigator (Marcel Veltkamp)Greenlane Clinical Centre, Auckland, Auckland, New Zealand
Contact: Principal Investigator (Margaret Wilsher)Bay of Plenty Clinical Trials Unit, Tauranga, Tauranga, New Zealand
Contact: Principal Investigator (Suzanne Poole)Dunedin Hospital, Dunedin, New Zealand
Waikato Hospital, Hamilton, New Zealand
Contact: Principal Investigator (Catherina Chang)Uniwersyteckie Centrum Kliniczne, Gdansk, Poland
Contact: Study coordinator (Amelia Szymanowska-Narloch, MD)Department of Pneumology of the University Hospital No 1, Lodz, Poland
Contact: Study coordinator (Wojciech Piotrowski, MD, PhD)Hospital Gregorio Marañon, Madrid, Madrid, Spain
Contact: Principal Investigator (Luis Puente Maestu)Hull University Teaching Hospital, Cottingham, East Yorkshire, United Kingdom
Contact: Principal Investigator (Simon Hart)Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom
Contact: Study coordinator (Helen Parfrey, MD)Leicester Biomedical Research Centre, Leicester, United Kingdom
Contact: Principal Investigator (Charlotte Swales)
מובילי המחקר
Avalyn Pharma, Inc.
Study Director
Avalyn Pharma Inc.